Cohen David E is a director of Timber Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Timber Pharmaceuticals, Inc.
18 Apr 23
4
Timber Pharmaceuticals, Inc.
19 Apr 22
4
Kadmon Holdings, Inc.
9 Nov 21
4
Timber Pharmaceuticals, Inc.
6 Jul 21
4
Kadmon Holdings, Inc.
13 May 21
3
Timber Pharmaceuticals, Inc.
25 Aug 20
4
Kadmon Holdings, Inc.
14 May 20
4
Dermira, Inc.
24 Feb 20
4
Dermira, Inc.
14 Jun 19
4
Dermira, Inc.
6 Jun 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 23 | TMBR Timber Pharmaceuticals | Common Stock, par value $0.001 per share | Grant | Acquire A | No | No | 0 | 4,100 | 0.00 | 6,100 |
15 Apr 23 | TMBR Timber Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.66 | 4,100 | 6.81 k | 4,100 |